- Peer-reviewed · Open access · CC BY 4.0
- Short title IIIJ
In-vitro In-vivo In-silico Journal
The In-vitro In-vivo In-silico Journal publishes work on drug discovery, development and delivery that uses in-vitro, in-vivo and in-silico approaches, read together: pharmacology, pharmacokinetics, toxicology, structure-activity relationships, efficacy and safety. Related life-science work is welcome.
The three lenses
One question, three kinds of evidence
The journal title names its methods. Each lens answers a different part of the same drug-development question.
- Lens 1
In vitro
Latin for “in glass”
- Cell-based assays and drug screening
- Toxicity and safety assessment
- Drug metabolism studies
- Lens 2
In vivo
Latin for “in the living”
- Animal models of disease and therapy
- Pharmacokinetics and pharmacodynamics
- Efficacy, safety and toxicology
- Lens 3
In silico
Computational modeling
- Molecular modeling and simulation
- Structure-activity relationships
- Cheminformatics and pharmacogenomics
Journal register
Reference information on the journal's ownership, editorial responsibility, rights, review, fees and preservation.
- Publisher and owner
- Open Access Pub
- The journal is owned and published by Open Access Pub and has published since 2018, beginning with Volume 1.
- Editor-in-Chief
- Giovanni Amabile
- ADIENNE Pharma & Biotech · Research and Development, Switzerland. The full board is listed on the Editorial Board page.
- Access and license
- Open access, CC BY 4.0
- All articles are free to read and reuse under the Creative Commons Attribution 4.0 International license; authors retain copyright.
- Peer review
- Independent peer review
- Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
- Article processing charge
- USD 1,200
- The same charge applies to every article type. Payable only after acceptance, with no submission fee; withdrawal after submission is subject to the journal's withdrawal policy.
- Preservation
- Portico
- IIIJ articles will be deposited in Portico, a not-for-profit digital-preservation archive. Read the preservation policy.
- Research integrity
- Crossref Similarity Check
- Submitted manuscripts are screened with Crossref Similarity Check, powered by iThenticate. See the Editorial Policies.
Current issue
Volume 1, Issue 1
Articles are published in regular issues. Every article is open access under CC BY 4.0.
Aims and Scope
Drug discovery, development and delivery
IIIJ treats drug discovery, development and delivery as its core and welcomes related life-science work. Topics include:
- Pharmacology and pharmacokinetics
- Toxicology and drug safety
- Structure-activity relationships
- Medicinal chemistry
- Cheminformatics and molecular modeling
- Pharmacogenomics
- Efficacy and safety evaluation
- Drug delivery
These areas are illustrative. Read the full Aims and Scope.
Published research
From the journal
Latest article
Recent articles
Drug Design Progress of In silico, In vitro and In vivo Researches
Qifeng Bai, Lanlan Li, Shanhui Liu, Shujun Xiao, Yu Guo
- Published
- Pages 16–37
Sulfonamides: Historical Discovery Development (Structure-Activity Relationship Notes)
Farah Yousef, Oussama Mansour, Jehad Herbali
- Published
- Pages 1–15
Archive entries keep the article type recorded at publication.
For authors
Article types
IIIJ publishes the article types listed here. Requirements for each type are set out in the Instructions for Authors.
- Original Research
- Review
- Systematic Review and Meta-Analysis
- Methods
- Short Communication
- Data Note
- Case Report
- Commentary
- Letter
Submission
Submit a manuscript to IIIJ
Please read the Instructions for Authors and the Editorial Policies before submitting. The article processing charge (USD 1,200 for every article type) is payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy.
Questions about a submission: info@openaccesspub.org